Back to School: How biopharma can reboot drug development. Access exclusive analysis here
An FDA advisory committee Tuesday voted 8-6 to recommend revising the label of Tamiflu oseltamivir from Roche (SWX:ROG) to replace language that suggests the drug
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury